Revenue
No reported data
Veradermics, Inc (MANE)
Price—Loading quote
Net income
2024
2025
Free cash flow
2024
2025
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Research & development | $62.1M | $23.3M |
| Operating expenses | $72.3M | $26.8M |
| Operating income | −$72.3M | −$26.8M |
| Net income | −$70.0M | −$26.5M |
| Basic EPSper diluted share | -$111.91 | -$37.05 |
| Diluted EPSper diluted share | -$111.91 | -$37.05 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 6, 2026Form 4 | SUVRETTA CAPITAL MANAGEMENT, LLC +3Director,TenPercentOwner | BuyCommon stock, par value $0.00001 per share · indirect | 19.3K | $36.55 | $706.8K | 520.5K |
| Feb 6, 2026Form 4 | SUVRETTA CAPITAL MANAGEMENT, LLC +3Director,TenPercentOwner | BuyCommon stock, par value $0.00001 per share · indirect | 11.2K | $35.97 | $402.3K | 501.1K |
| Feb 5, 2026Form 4/A | CHILDS JOHN WDirector | BuyCommon Stock · indirect | 294.1K | $17.00 | $5.00M | 294.1K |
| Feb 5, 2026Form 4 | SUVRETTA CAPITAL MANAGEMENT, LLC +3Director,TenPercentOwner | BuyCommon stock, par value $0.00001 per share · indirect | 16.6K | $39.80 | $659.2K | 489.9K |
| Feb 5, 2026Form 4 | SUVRETTA CAPITAL MANAGEMENT, LLC +3Director,TenPercentOwner | BuyCommon stock, par value $0.00001 per share · indirect | 17.8K | $38.67 | $689.7K | 473.4K |